身高状态影响危重患儿死亡风险
该研究基于日本重症患者数据库(JIPAD),纳入2015年4月至2020年3月收治的16岁以下ICU患儿共6377例,按年龄和性别计算身高标准差评分,将评分<-2定义为矮身材。矮身材组占27.2%,其ICU全因死亡率显著高于身高正常组(3.6% vs 1.4%,p<0.01)。多因素logistic回归显示矮身材与ICU死亡独立相关(OR=2.73,95%CI 1.81-4.11);Fine-Gray竞争风险模型显示矮身材与每日ICU出院机会降低相关(HR 0.85,95%CI 0.81-0.90,p<0.01)。作者认为身高应纳入儿科重症风险评估与管理策略。
要点
- 矮身材(身高SD评分<-2)占危重患儿27.2%,其ICU死亡率3.6% vs 身高正常组1.4%(p<0.01)。
- 多因素logistic回归:矮身材与ICU死亡独立相关(OR=2.73,95%CI 1.81-4.11)。
- Fine-Gray模型:矮身材与每日ICU出院机会降低相关(HR 0.85,95%CI 0.81-0.90,p<0.01)。
- 作者认为,儿科重症风险评估和管理策略应考虑身高因素。
适用人群与场景
- 日本全国数据库(JIPAD)中2015年4月至2020年3月收治的16岁以下ICU患儿,共6377例。
诊断标准与关键阈值
- 矮身材定义:基于年龄和性别计算的身高标准差评分(SD评分)<-2。
研究设计与关键结果
- 研究类型:基于日本全国数据库(JIPAD)的回顾性队列研究,纳入16岁以下ICU患儿6377例。
- 矮身材组占27.2%,ICU死亡率3.6% vs 身高正常组1.4%(p<0.01)。
- 多因素logistic回归:矮身材与ICU死亡独立相关(OR=2.73,95%CI 1.81-4.11)。
- Fine-Gray竞争风险模型:矮身材与每日ICU出院机会降低相关(HR 0.85,95%CI 0.81-0.90,p<0.01)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,身高应纳入儿科重症风险评估和管理策略以改善预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Anthropometric measurements are crucial in pediatric critical care, but the impact of height on ICU outcomes is underexplored despite a substantial number of short-for-age children in ICUs. Previous studies suggest that short stature increases the risk of poor clinical outcomes. This study examines the relationship between short stature and ICU outcomes.
METHODS: We conducted a retrospective cohort study using a Japanese nationwide database (the Japanese Intensive Care Patient Database; JIPAD), which included pediatric patients under 16 years admitted to ICUs from April 2015 to March 2020. Height standard deviation scores (SD scores) were calculated based on age and sex. Short-stature patients were defined as height SD score < - 2. The primary outcome was all-cause ICU mortality, and the secondary outcome was the length of stay in ICU.
RESULTS: Out of 6,377 pediatric patients, 27.2% were classified as having short stature. The ICU mortality rate was significantly higher in the short-stature group compared to the normal-height group (3.6% vs. 1.4%, p < 0.01). Multivariable logistic regression showed that short stature was independently associated with increased ICU mortality (OR = 2.73, 95% CI 1.81-4.11). Additionally, the Fine-Gray subdistribution hazards model indicated that short stature was associated with a lower chance of ICU discharge for each additional day (HR 0.85, 95% CI 0.81-0.90, p < 0.01).
CONCLUSIONS: Short stature is a significant risk factor for increased ICU mortality and prolonged ICU stay in critically ill children. Height should be considered in risk assessments and management strategies in pediatric intensive care to improve outcomes.
参考来源
- Nosaka N, Anzai T, Wakabayashi K, et al. Height status matters for risk of mortality in critically ill children. J Intensive Care. 2024. PMID: 39473000. doi:10.1186/s40560-024-00757-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。